Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways

Michael A Crackower1, Gavin Y Oudit, Ivona Kozieradzki

  • 1IMBA, Institute for Molecular Biotechnology of the Austrian Academy of Sciences, c/o Dr. Bohr Gasse 7, A-1030, Vienna, Austria.

Cell
|September 26, 2002
PubMed

Insights

The PTEN/PI3K pathway impacts heart cell size and function. PTEN loss causes hypertrophy and reduced contractility, with PI3Kgamma regulating contractility via cAMP signaling.

Area of Science:

  • Cardiovascular Biology
  • Molecular Signaling
  • Cellular Physiology

Background:

  • The Phosphatase and Tensin homolog (PTEN) and Phosphoinositide 3-kinase (PI3K) signaling pathway is crucial for regulating cellular processes.
  • Dysregulation of this pathway is implicated in various cardiovascular diseases.

Purpose of the Study:

  • To investigate the in vivo role of PTEN in cardiomyocyte hypertrophy and cardiac function.
  • To elucidate the specific roles of different PI3K isoforms in mediating PTEN's effects on the heart.

Main Methods:

  • Utilized cardiomyocyte-specific PTEN knockout mouse models.
  • Generated and analyzed double-mutant mice to genetically uncouple hypertrophy and contractility defects.
  • Investigated the involvement of PI3K isoforms (PI3Kalpha and PI3Kgamma) and cyclic AMP (cAMP) signaling.

Main Results:

  • Cardiomyocyte-specific PTEN inactivation led to cardiac hypertrophy and a significant decrease in cardiac contractility.
  • Cardiac hypertrophy and contractility defects were found to be genetically separable.
  • PI3Kalpha mediated changes in cardiomyocyte size, while PI3Kgamma negatively regulated cardiac contractility.
  • PI3Kgamma's inhibition of cardiac contractility was linked to suppressed cAMP production, and hypercontractility could be restored by blocking cAMP function.

Conclusions:

  • PTEN plays a vital role in regulating cardiomyocyte hypertrophy and G protein-coupled receptor (GPCR) signaling in vivo.
  • The PTEN-PI3Kgamma pathway is identified as a key modulator of heart muscle contractility.
  • Specific PI3K isoforms have distinct roles in cardiac physiology, highlighting therapeutic targets for cardiovascular conditions.

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...